Arcus Biosciences, Inc. (RCUS) has 67 open-market insider trades by 11 insiders since 2018. The most active filer is Terry J. Rosen, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 10% Owner | — | 3 | $354.5M | 2025-02-18 |
| Gilead Sciences Inc. | 10% Owner | — | 1 | $220.3M | 2021-01-31 |
| Jennifer Jarrett | COO | — | 14 | $8.9M | 2026-01-23 |
| Terry J. Rosen | CEO | — | 15 | $7.8M | 2026-01-23 |
| Juan C. Jaen | Pres | — | 11 | $3.1M | 2026-07-10 |
| Kathryn E. Falberg | Dir | — | 5 | $1.8M | 2026-06-11 |
| William Grossman | — | — | 6 | $883K | 2021-06-17 |
| Carolyn C. Tang | CLO | — | 5 | $638K | 2026-06-11 |
| Robert C. Goeltz II | CFO | — | 4 | $570K | 2026-05-11 |
| Yasunori Kaneko | Dir | — | 2 | $461K | 2026-06-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alexander Azoy | CAO | Sell | $85K | 2026-08-21 |
| Juan C. Jaen | President | Sell | $2.0M | 2026-07-09 |
| Juan C. Jaen | President | Sell | $878K | 2026-06-22 |
| Alexander Azoy | CAO | Sell | $66K | 2026-06-01 |
| Robert C. Goeltz II | CFO | Sell | $199K | 2026-05-11 |
| Juan C. Jaen | President | Sell | $681K | 2026-01-05 |
Companies that share insiders with RCUS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Robert C. Goeltz II | CFO | Sell | $153K | 2025-12-31 |
| Juan C. Jaen | President | Sell | $688K | 2025-12-16 |
| Richard Markus | — | Sell | $420K | 2025-12-16 |
| Terry J. Rosen | CEO | Sell | $2.4M | 2025-12-16 |
| Carolyn C. Tang | CLO | Sell | $637K | 2025-12-16 |
| Alexander Azoy | CAO | Sell | $344K | 2025-12-16 |
| Robert C. Goeltz II | CFO | Sell | $557K | 2025-12-16 |
| Juan C. Jaen | President | Sell | $4.1M | 2025-12-04 |
| Robert C. Goeltz II | CFO | Sell | $125K | 2025-11-26 |